<DOC>
	<DOC>NCT02091024</DOC>
	<brief_summary>The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Ecklonia cava extract on hyperlipidemia.</brief_summary>
	<brief_title>Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava</brief_title>
	<detailed_description>The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Ecklonia cava extract on hyperlipidemia. The investigators measured improvement of lipid profile, including total cholesterol, triglyceride, HDL-cholesterol, and LDL-cholesterol.</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Mild hypercholesterolemic subjects(≥200mg/dL of total cholesterol or ≥110mg/dL of LDLcholesterol) Selfreported pregnancy, lactation Prevalent heart disease, cancer, renal disorder, or diabetes mellitus, and use of lipidlowering drugs</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>